Xencor (XNCR) Asset Utilization Ratio (2014 - 2026)
Xencor's (XNCR) quarterly Asset Utilization Ratio came in at 0.12 in Q1 2026, down 11.88% year-on-year from 0.14 in Q1 2025, and down 16.12% on a QoQ basis from 0.14 in Q4 2025.
Xencor (XNCR) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Xencor (XNCR) has 13 years of Asset Utilization Ratio data on file, last reported at 0.12 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 11.88% year-over-year to 0.12 in Q1 2026; TTM through Mar 2026 was 0.12, a 11.88% decrease from a year earlier, with the FY2025 full-year figure at 0.14, up 19.23% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.12, down from 0.14 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for XNCR reached as high as 0.39 in Q1 2022 and fell as low as 0.11 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.19 across 5 years, with a median of 0.17 in 2025.
- Across the five-year window, Asset Utilization Ratio surged 116.2% in 2022 and plunged 69.12% in 2023, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.2 in 2022, then advanced by 2.37% to 0.2 in 2023, then slumped by 43.51% to 0.11 in 2024, then increased by 27.17% to 0.14 in 2025, then fell by 16.12% to 0.12 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.12 in Q1 2026, 0.14 in Q4 2025, and 0.17 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.18 |
| Dec 31, 2023 | 0.20 |
| Sep 30, 2023 | 0.19 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 0.35 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.39 |
| Dec 31, 2021 | 0.36 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.26 |